 |
Articles: Drug Trials |
Prior Articles
A New Approach to Managing Safety Information in Clinical Trials
PharmExec, 09/23/09
Bayer’s Novel Anti-Cancer Compound Regorafenib Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
BayNews International, 09/23/09
Free full text
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
Amgen, 09/23/09
Free full text
Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
Amgen, 09/23/09
Free full text
QUARITE (quality of care, risk management and technology in obstetrics): a cluster-randomized trial of a multifaceted intervention to improve emergency obstetric care in Senegal and Mali
Trials, 09/22/09
Free full text
Abbotts XIENCE V Continues to Outperform TAXUS with Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial
Abbott, 09/22/09 Boston Scientific PROMUS and First-Generation TAXUS Express Stents Continue Excellent Performance in SPIRIT III Trial
Boston Scientific, 09/22/09
Free full text
Patients Begin Enrolling into Investigator-Sponsored Phase 2 Trial of Antigenics? Oncophage Cancer Vaccine in Newly Diagnosed Glioma
Antigenics, 09/22/09
Free full text
ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab
ARIAD Pharmaceuticals, 09/22/09
Free full text
Pivotal Registration Trial of OPAXIO Maintenance Therapy in First-Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients, Cell Therapeutics and the Gynecologic Oncology Group Discuss Potential for Early Interim Analysis
Cell Therapeutics, 09/22/09
Free full text
Medtronics Resolute Drug-Eluting Stent Maintains Strong, Sustained Efficacy and Safety in Long-Term Follow-Up
Medtronic, 09/22/09
Free full text
Endeavor Stent Reduced Risk of Heart Attack/Cardiac Death by 48% at Three Years Compared to Taxus Stent in Large Study
Medtronic, 09/22/09
Free full text
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Amgen, 09/22/09
Free full text
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Boston Scientific, 09/21/09
Free full text
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)
Leukemia and Lymphoma, 09/18/09 Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
PLoS Medicine, 09/18/09
Free full text
Recent Research Supports the Importance of Starting Treatment Early in Patients with Multiple Sclerosis
BayNews International, 09/18/09
Free full text
Positive Phase IIb Results for GSK1838262 (XP13512) Reported for Neuropathic Pain Associated with Post-Herpetic Neuralgia
XenoPort, 09/18/09 Head-to-head trial demonstrates Viramune®’s similar efficacy and more favourable effect on lipid profile compared to atazanavir/ritonavir
Boehringer Ingelheim, 09/17/09
Free full text
18 month Follow-up Data on Phase III Study of Pixantrone in Late Stage Relapsed or Refractory, Aggressive Non-Hodgkins Lymphoma Continues to Demonstrate Significant Improvement in Complete Remission and Progression Free Survival Over Standard Chemotherap
Cell Therapeutics, 09/17/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
